Biogen Idec Inc (BIIB)

BIIB (NASDAQ:Drugs)
$392.80
pos +40.00
+11.00%
Today's Range: 372.75 - 397.00 | BIIB Avg Daily Volume: 1,762,000
Last Update: 01/30/15 - 12:16 PM EST
Volume: 2,214,812
YTD Performance: 4.07%
Open: $372.75
Previous Close: $353.25
52 Week Range: $272.02 - $366.17
Oustanding Shares: 236,155,407
Market Cap: 82,933,055,830
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 11 11 11
Moderate Buy 1 1 1 1
Hold 4 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.65 1.65 1.65
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 33.26
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
33.26 33.20 25.58
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.12% 15.65% 197.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue 32.60 0.47 0.14
Net Income 34.90 1.07 0.27
EPS 35.80 0.97 0.25
Earnings for BIIB:
EBITDA 1.90B
Revenue 5.81B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $3.83 $4.03 $16.67 $20.18
Number of Analysts 1 1 2 2
High Estimate $3.83 $4.03 $16.77 $20.56
Low Estimate $3.83 $4.03 $16.56 $19.79
Prior Year $2.45 $3.49 $13.79 $16.67
Growth Rate (Year over Year) 56.33% 15.47% 20.85% 21.06%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishBiogen Idec numbers boosted at Nomura

Jan 30, 2015 | 7:29 AM EST

Shares of BIIB now seen reaching $401, according to Nomura. Estimates also upped, given the company's new guidance. Neutral rating.

By

Doug Kass

 | Jan 28, 2015 | 7:10 AM EST
U.S. futures higher: S&P 500 futures +4 and Nasdaq futures are 37 handles higher -- thanks to Apple's (AAPL) blow-out quarter. European markets have flat-lined. Japan's Nikkei 225 is +0.15%. Little in the news. Within the index, energy and tech lagged, while staples health care and telecoms outperformed. Nintendo reported weak results while Komatsu's performance was good.  The Chinese market is down 1.41% on the back of reports on another crackdown on margin trading. Every sub group was in the red. Gold is down by $1/oz and crude oil is -$0.70.(I was stopped out of my USO long for a $0.18 gain yesterday). Natural gas is down by 2.7% to $2.90  and copper is up +0.5%. The U.S. dollar is +0.08% and the euro is down -0.23%. The yield on the 10-year U.S. Treasury note is down by two basis points to 1.795% (a lot of volatility has entered this market in the last few days- just like currencies). Sovereign-debt yields in Greece are rising big time.   There is no clea
By

Jim Cramer

 | Jan 26, 2015 | 3:58 PM EST

These are surefire indications of a bountiful tape.

By

Jim Cramer

 | Jan 15, 2015 | 3:40 PM EST

Use the overall weakness to pick up the America First stocks.

By

Timothy Collins

 | Jan 8, 2015 | 10:09 AM EST
Do you need to pick one name?

bullishBiogen Idec rated new Overweight at Barclays

Jan 6, 2015 | 7:49 AM EST

Coverage of BIIB was started with an Overweight rating, Barclays said. $425 price target. Company has a solid pipeline and Tecfidera should drive growth. 

By

Carolyn Boroden

 | Dec 29, 2014 | 9:00 AM EST

Here's how to trade some key price relationships.

By

Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

By

Jim Cramer

 | Dec 19, 2014 | 7:16 PM EST

There had been no catalysts.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

Market slightly down despite the boost Amazon (AMZN) is giving the NASDAQ. Biotech also co...
There are a number of interesting technical signals on the weekly and daily Berkshire Hath...
TheStreet breaks down three things a newly minted publicly traded Shake Shack must do to h...

if you got some sell half right now

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.